RP-9056

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRP-9056
Drug Alias NameGPCR-119 agonist (Rhizen Pharmaceuticals)GPCR-119 agonist (Rhizen Pharmaceuticals)RP-9056
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucose-dependent insulinotropic receptor agonistsInsulin release stimulants
TargetsGlucagon-like peptide 1 receptorInsulin receptorGlucose-dependent insulinotropic receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRhizen Pharmaceuticals Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRhizen Pharmaceuticals Sa
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A